Goodpasture syndrome differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
== Overview == | == Overview == | ||
Goodpasture syndrome should be differentiated from other diseases presenting as hemeturia and hemoptysis. It should also be differentiated from other causes of small vessel vasculitis. | Goodpasture syndrome should be differentiated from other diseases presenting as fever, hemeturia and hemoptysis. It should also be differentiated from other causes of small vessel vasculitis. | ||
== Differential Diagnosis == | == Differential Diagnosis == | ||
Goodpasture syndrome should be differentiated from other diseases presenting as hemeturia | Goodpasture syndrome should be differentiated from other diseases presenting as fever, hemeturia, hemoptysis. It should also be differentiated from other causes of small vessel vasculitis. The differentials include the following: | ||
<small><small> | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | |||
! colspan="3" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases | |||
| colspan="8" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestations''' | |||
! colspan="9" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Para-clinical findings | |||
| colspan="1" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Gold standard''' | |||
! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings | |||
|- | |||
| colspan="5" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Symptoms''' | |||
! colspan="3" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" | Physical examination | |||
|- | |||
! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings | |||
! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging | |||
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology | |||
|- | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Headache | |||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Fever | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Arthralgia | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Claudication | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Bruit | |||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |HTN | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Focal neurological disorder | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Biomarker | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CBC | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |ESR | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound/ Echocardiography | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | |||
|- | |||
! rowspan="19" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Small-Vessel Vasculitis | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[ANCA-associated vasculitis]] | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Granulomatosis with polyangiitis|Granulomatosis with polyangiitis (Wegener’s)]]<ref name="pmid27195187">{{cite journal| author=Kubaisi B, Abu Samra K, Foster CS| title=Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations. | journal=Intractable Rare Dis Res | year= 2016 | volume= 5 | issue= 2 | pages= 61-9 | pmid=27195187 | doi=10.5582/irdr.2016.01014 | pmc=4869584 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27195187 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C-ANCA|Anti-PR3 antibody (C-ANCA)]] (90%), [[P-ANCA|Anti-MPO antibody (P-ANCA)]] (10%) | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Normochromic anemia|Normochromic normocytic anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]], [[Hypoalbuminemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Consolidation (medicine)|Consolidation]], Patchy or diffuse [[Ground glass opacification on CT|ground-glass opacities]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Occlusion]] or [[stenosis]] of [[LAD]] and [[RCA]] in [[coronary angiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Single or multiple [[nodules]] and [[Mass|masses]] with [[cavitation]] in [[CXR]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Parenchymal]] [[necrosis]], [[Granulomatous]] [[inflammation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Conjunctivitis]], | |||
[[Episcleritis]], | |||
[[Uveitis]], | |||
[[Optic nerve]] vasculitis | |||
|- | |||
! rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Immune complexes|Immune complex]] small-vessel vasculitis | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Goodpasture disease|Anti-glomerular basement membrane disease]]<ref name="pmid28515156">{{cite journal |vauthors=McAdoo SP, Pusey CD |title=Anti-Glomerular Basement Membrane Disease |journal=Clin J Am Soc Nephrol |volume=12 |issue=7 |pages=1162–1172 |date=July 2017 |pmid=28515156 |doi=10.2215/CJN.01380217 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-GBM antibody|Anti-GBM antibodies]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hypochromic anemia|Hypochromic microcytic anemia]], [[Thrombocytopenia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓[[C3 (complement)|C3]] level | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary hemorrhage]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal [[kidneys]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Alveolar]] infiltrates spreading from the [[hilum]] in [[CXR]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Cellular crescents in the [[glomeruli]], [[Pulmonary hemorrhage|Intra-alveolar hemorrhages]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-GBM antibody|Anti-GBM antibodies]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hemoptysis]], [[Hematuria]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cryoglobulinemia|Cryoglobulinemic vasculitis]]<ref name="pmid16344620">{{cite journal |vauthors=Ferri C, Mascia MT |title=Cryoglobulinemic vasculitis |journal=Curr Opin Rheumatol |volume=18 |issue=1 |pages=54–63 |date=January 2006 |pmid=16344620 |doi= |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C4A|C4 component]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antinuclear antibodies|ANA]], [[hypocomplementemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |R/O underlying [[malignancy]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Stenosis]] or [[Occlusion|occlusions]] of the [[Visceral|visceral arteries]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Bacterial endocarditis]] in [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Interstitial]] involvement or [[pleural effusions]] in [[CXR]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[HCV]]-associated [[proteins]] in [[vasculitic]] [[skin]], Intraluminal [[cryoglobulin]] deposits | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Acrocyanosis]], [[Retinal]] [[hemorrhage]], [[Purpura]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis C virus]]-associated [[Cryoglobulinemia|cryoglobulinemic vasculitis]]<ref name="pmid28810602">{{cite journal| author=Guo QY, Wu M, Wang YW, Sun GD| title=Hepatitis C virus-associated cryoglobulinemia with membrano-proliferative glomerulonephritis treated with prednisolone and interferon: A case report. | journal=Exp Ther Med | year= 2017 | volume= 14 | issue= 2 | pages= 1395-1398 | pmid=28810602 | doi=10.3892/etm.2017.4671 | pmc=5525644 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28810602 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hepatitis C|HCV RNA]], [[Cryoglobulins]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓[[C4A|Serum C4]], Positive [[RF]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Increased [[hepatic]] [[echogenicity]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hepatomegaly]], [[Splenomegaly]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Increased [[hepatic]] [[echogenicity]] in [[MRI]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Vasculitic]] skin, [[Antigen]] infilteration in [[lesions]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hepatitis C|HCV RNA]], [[Histopathology|Histological confirmation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Palpable [[purpura]], [[Microscopic hematuria]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Gastrointestinal diseases|Gastrointestinal disease]] | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Acute mesenteric ischemia]]<ref name="pmid24267504">{{cite journal |vauthors=Sise MJ |title=Acute mesenteric ischemia |journal=Surg. Clin. North Am. |volume=94 |issue=1 |pages=165–81 |date=February 2014 |pmid=24267504 |doi=10.1016/j.suc.2013.10.012 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[FABP1|I-FABP]], [[GSTA1|Alpha-GST]], [[Ischemia-modified albumin (IMA)]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], ↑[[Hematocrit|HCT]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | ↑[[Amylase]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Bowel]] wall thickening, [[Pneumatosis intestinalis|Intestinal pneumatosis]], [[Mesenteric ischemia|Portomesenteric]] thrombosis | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Mesenteric vein thrombosis|Mesenteric venous thrombosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Artery|Arterial]] [[stenosis]] or occlusion of the [[Celiac artery|celiac]] or [[superior mesenteric arteries]] in [[duplex ultrasound]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Ileus]] with distended loops of [[bowel]], [[Bowel]] wall thickening in [[abdominal X-ray]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Superficial [[Mucosal bleeding|mucosal hemorrhage]], [[edema]] and [[necrosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |History and [[physical examination]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Abdominal pain]], [[Distension]], [[Absent bowel sounds]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cardiovascular diseases|Cardiovascular disease]] | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Infective Endocarditis]]<ref name="pmid19665088">{{cite journal| author=McDonald JR| title=Acute infective endocarditis. | journal=Infect Dis Clin North Am | year= 2009 | volume= 23 | issue= 3 | pages= 643-64 | pmid=19665088 | doi=10.1016/j.idc.2009.04.013 | pmc=2726828 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19665088 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[NT-proBNP]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Normochromic anemia|Normochromic-normocytic anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hypergammaglobulinemia|Hyperglobulinemia]], [[Cryoglobulinemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Metastatic]] [[infections]], such as [[Splenic infarction|splenic infarct]], [[Renal infarct|renal infarcts]], or [[psoas abscess]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Vegetation (pathology)|Vegetation]], [[abscess]], or new dehiscence of a [[Prosthetic valves|prosthetic valve]]<nowiki/>in [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Vertebral osteomyelitis]] in [[Magnetic resonance imaging|MRI]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Vegetation (pathology)|Vegetation]] or [[Abscess|intracardiac abscess]] demonstrating active [[endocarditis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Echocardiography]] ([[TTE]]) | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Janeway lesions]], [[Osler nodes]], [[Roth's spot|Roth spots]], [[Vertebral osteomyelitis]] | |||
|- | |||
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary disease]] | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non small cell lung cancer|Non-Small Cell Lung Cancer]]<ref name="pmid18452692">{{cite journal| author=Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA| title=Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. | journal=Mayo Clin Proc | year= 2008 | volume= 83 | issue= 5 | pages= 584-94 | pmid=18452692 | doi=10.4065/83.5.584 | pmc=2718421 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18452692 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[EGFR]], ''[[ROS1]],'' [[Anaplastic lymphoma kinase|EML4-''ALK'']], [[PD-L1]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hypercalcemia]], [[Hyponatremia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary|Pulmonary lesion]] or [[mass]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary]] marginal [[lesions]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cancer staging|Staging]] and response to treatment in [[Positron emission tomography|PET-CT]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Adenocarcinoma of the lung pathophysiology|Adenocarcinoma]], [[Squamous cell carcinoma of the lung pathophysiology|Squamous cell carcinoma]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Computed tomography|High resolution CT-scan]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cough]], [[Hemoptysis]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Small cell lung cancer|Small Cell Lung Cancer]]<ref name="pmid16226617">{{cite journal |vauthors=Jackman DM, Johnson BE |title=Small-cell lung cancer |journal=Lancet |volume=366 |issue=9494 |pages=1385–96 |date=2005 |pmid=16226617 |doi=10.1016/S0140-6736(05)67569-1 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |''[[P53 (protein)|p53]],'' [[Thyroid transcription factor-1|Thyroid transcription factor-1 (TTF1)]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hyponatremia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Large [[hilar]] mass with bulky [[mediastinal]] [[adenopathy]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Endobronchial [[ultrasound]] (EBUS) | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Standard [[Staging (pathology)|staging]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Spindled cells with dark [[nuclei]], scant [[cytoplasm]], and fine, granular [[Chromatin|nuclear chromatin]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Computed tomography|High resolution CT-scan]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cough]], [[Hemoptysis]] | |||
|- | |||
! rowspan="7" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hematologic disease]] | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hemolytic-uremic syndrome|Hemolytic-Uremic Syndrome]]<ref name="pmid11691946">{{cite journal |vauthors=Corrigan JJ, Boineau FG |title=Hemolytic-uremic syndrome |journal=Pediatr Rev |volume=22 |issue=11 |pages=365–9 |date=November 2001 |pmid=11691946 |doi= |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C5a|C5b-9]], [[ADAMTS13]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anemia]], [[Thrombocytopenia]], [[Reticulocytosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Lactate dehydrogenase|Lactate dehydrogenase (LDH)]], [[Hypercalcemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thalami]], [[brainstem]], or [[cerebellum]] abnormality | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cerebral]] [[microangiopathy]] or [[hypertension]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Hypoechoic [[kidney]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Abnormal hyperintensity in the [[Brain|brain cisterns]] in [[MRI]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thromboses|Microthromboses]] include [[Fibrin|fibrin thrombi]] that may occlude the [[glomerular]] tuft | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled with [[Medical laboratory|laboratory abnormalities]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hematuria]], [[Proteinuria]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Chronic Lymphocytic Leukemia|Chronic Lymphocytic Leukemia (CLL)]]<ref name="pmid15561682">{{cite journal |vauthors=Byrd JC, Stilgenbauer S, Flinn IW |title=Chronic lymphocytic leukemia |journal=Hematology Am Soc Hematol Educ Program |volume= |issue= |pages=163–83 |date=2004 |pmid=15561682 |doi=10.1182/asheducation-2004.1.163 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[CD5]], [[CD19]], [[CD20]], IgV<sub>H</sub> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Absolute [[lymphocytosis]], Smudge cells | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Flow cytometry]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cancer staging|Staging]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Large atypical [[Cells (biology)|cells]], cleaved cells, and [[prolymphocytes]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Chromosomal]] and [[genetic testing]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Easy bruising]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hypereosinophilic syndrome|Hypereosinophilic Syndrome]]<ref name="pmid19630574">{{cite journal |vauthors=Klion A |title=Hypereosinophilic syndrome: current approach to diagnosis and treatment |journal=Annu. Rev. Med. |volume=60 |issue= |pages=293–306 |date=2009 |pmid=19630574 |doi=10.1146/annurev.med.60.062107.090340 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[IgE]], [[CD117]] with [[CD2]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Eosinophilia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑Serum [[tryptase]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Lymphadenopathy]] and [[splenomegaly]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Intracardiac thrombus|Intracardiac thrombi]] in [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Reticulin|Reticulin stain]] for [[myelofibrosis]] and [[tryptase]] staining for [[mast cells]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled with [[Medical laboratory|laboratory abnormalities]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Splinter hemorrhages]], [[Raynaud phenomenon]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non-Hodgkin lymphoma|Non-Hodgkin Lymphoma]]<ref name="pmid22835603">{{cite journal |vauthors=Shankland KR, Armitage JO, Hancock BW |title=Non-Hodgkin lymphoma |journal=Lancet |volume=380 |issue=9844 |pages=848–57 |date=September 2012 |pmid=22835603 |doi=10.1016/S0140-6736(12)60605-9 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C-myc|MYC]], [[BCL2-like 1 (gene)|BCL2]], [[BCL6]], and [[TP53]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Lymphocytosis]], [[Anemia]], [[Thrombocytopenia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Lactate dehydrogenase|Lactate dehydrogenase (LDH)]], [[Hypercalcemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Enlarged [[Lymph node|lymph nodes]], [[Hepatosplenomegaly]], Filling defects in the [[liver]] and [[spleen]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hepatosplenomegaly]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Mediastinal lymphadenopathy]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Small cleaved or noncleaved, intermediate, or large cell with a follicular or diffuse pattern | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Surgically excised tissue [[biopsy]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Easy bruising]], [[Testicular mass]], [[Skin lesions|Skin lesion]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Serum sickness|Serum Sickness]]<ref name="pmid2867672">{{cite journal |vauthors=Lin RY |title=Serum sickness syndrome |journal=Am Fam Physician |volume=33 |issue=1 |pages=157–62 |date=January 1986 |pmid=2867672 |doi= |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[IL-1]], [[IL-6]], [[TNF]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukopenia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Gammopathy|Polyclonal gammopathy]], ↑[[Cr]], [[Cryoglobulinemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Arteritic lesions are focal, [[necrotizing]], and [[inflammatory]] involving all layers of the [[artery]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled with [[Medical laboratory|laboratory abnormalities]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hematuria]], [[Skin rash]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Disseminated intravascular coagulation|Disseminated Intravascular Coagulation]]<ref name="pmid25535423">{{cite journal| author=Venugopal A| title=Disseminated intravascular coagulation. | journal=Indian J Anaesth | year= 2014 | volume= 58 | issue= 5 | pages= 603-8 | pmid=25535423 | doi=10.4103/0019-5049.144666 | pmc=4260307 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25535423 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Fibrin degradation product|Fibrin degradation product (FDP)]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thrombocytopenia]], [[Schistocytes]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[D-dimer]], [[aPTT]] and [[PT]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Intracranial hemorrhage]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Ischemia]] and [[necrosis]] due to [[Fibrin|fibrin deposition]] in small and medium-sized [[vessels]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled with [[Medical laboratory|laboratory abnormalities]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | [[Cyanosis|Acral cyanosis]], [[Hemorrhagic]] skin [[Infarction|infarctions]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Idiopathic thrombocytopenic purpura|Idiopathic Thrombocytopenic Purpura]]<ref name="pmid27441004">{{cite journal| author=Nomura S| title=Advances in Diagnosis and Treatments for Immune Thrombocytopenia. | journal=Clin Med Insights Blood Disord | year= 2016 | volume= 9 | issue= | pages= 15-22 | pmid=27441004 | doi=10.4137/CMBD.S39643 | pmc=4948655 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27441004 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[FCGR2B|FC gamma receptors (FCGR) IIb]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anemia]], [[Thrombocytopenia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[HIV]], [[ANA]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |R/O other causes | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |R/O [[splenomegaly]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Increased number of normal morphologic [[megakaryocytes]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled with [[thrombocytopenia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Easy bruising]], [[Purpura]] | |||
|- | |||
! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic disease]] | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Sarcoidosis]]<ref name="pmid27454074">{{cite journal| author=Chiarchiaro J, Chen BB, Gibson KF| title=New molecular targets for the treatment of sarcoidosis. | journal=Curr Opin Pulm Med | year= 2016 | volume= 22 | issue= 5 | pages= 515-21 | pmid=27454074 | doi=10.1097/MCP.0000000000000304 | pmc=5152532 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27454074 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | [[IL-2]] and [[Interferon gamma|IFN-γ]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mild [[anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Angiotensin-converting enzyme|ACE]], ↑[[Vitamin D|1, 25-dihydroxyvitamin D]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Active [[alveolitis]] or [[fibrosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hepatosplenomegaly]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Bilateral [[Adenopathy|hilar adenopathy]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Granuloma|Noncaseating granulomas (NCGs)]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Heart block]], [[Ocular disease|Ocular lesion]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Legionella Infections|Legionella Infection]]<ref name="pmid12491204">{{cite journal |vauthors=Murdoch DR |title=Diagnosis of Legionella infection |journal=Clin. Infect. Dis. |volume=36 |issue=1 |pages=64–9 |date=January 2003 |pmid=12491204 |doi=10.1086/345529 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cytokine|Inflammatory cytokines]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]] with [[left shift]], [[Thrombocytosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[D-dimer]], [[Fibrin degradation product|FDP]], [[Hyponatremia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pleural effusion]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nonspecific and indistinguishable [[CXR]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Intra-[[alveolar]] [[inflammation]], [[Abscesses|Microabscesses]] in the [[parenchyma]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Sputum culture]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cough]], [[Diarrhea]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic lupus erythematosus]]<ref name="Tsokos2011">{{cite journal|last1=Tsokos|first1=George C.|title=Systemic Lupus Erythematosus|journal=New England Journal of Medicine|volume=365|issue=22|year=2011|pages=2110–2121|issn=0028-4793|doi=10.1056/NEJMra1100359}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-dsDNA antibody|Anti dsDNA]], [[ANA]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | [[Leukopenia]], [[Lymphopenia]], [[Anemia]], [[Thrombocytopenia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]], | |||
↑[[ALT]] or [[AST]], [[Proteinuria]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Interstitial lung disease, [[Pneumonitis]], [[Pulmonary emboli]], [[Hemorrhage|Alveolar hemorrhage]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Aneurysms]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pericardial effusion]], [[pulmonary hypertension]], or verrucous [[Libman-Sacks endocarditis]] in [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Central nervous system|Central nervous system (CNS)]] [[Systemic lupus erythematosus|lupus]] white-matter changes in [[MRI]] | |||
! align="center" style="padding: 5px 5px; background: #F5F5F5;" |Staging [[lupus nephritis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-dsDNA antibody|Anti-dsDNA antibody test]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Skin rashes]] or [[photosensitivity]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Relapsing polychondritis]]<ref name="pmid27708954">{{cite journal| author=Emmungil H, Aydın SZ| title=Relapsing polychondritis. | journal=Eur J Rheumatol | year= 2015 | volume= 2 | issue= 4 | pages= 155-159 | pmid=27708954 | doi=10.5152/eurjrheum.2015.0036 | pmc=5047229 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27708954 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cryoglobulins]], [[ANA]], [[C-ANCA]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Calcification]] of [[Cartilaginous|cartilaginous structures]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Aortic root|Aortic root dilatation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Aortic root|Aortic root dilatation]] and degree of [[aortic regurgitation]] in [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Tracheal stenosis]] in [[CXR]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Chondrolysis, [[Chondritis]], Perichondritis | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled with imaging | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Ear pain]] and redness, [[Polyarthritis]] | |||
|- | |||
|} | |||
</small></small> | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
[[Category: Medicine]] | |||
[[Category: Up-To-Date]] | |||
[[Category: Primary care]] | |||
[[Category: Rheumatology]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 06:05, 29 April 2018
Goodpasture syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Goodpasture syndrome differential diagnosis On the Web |
American Roentgen Ray Society Images of Goodpasture syndrome differential diagnosis |
Risk calculators and risk factors for Goodpasture syndrome differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]
Overview
Goodpasture syndrome should be differentiated from other diseases presenting as fever, hemeturia and hemoptysis. It should also be differentiated from other causes of small vessel vasculitis.
Differential Diagnosis
Goodpasture syndrome should be differentiated from other diseases presenting as fever, hemeturia, hemoptysis. It should also be differentiated from other causes of small vessel vasculitis. The differentials include the following:
References
- ↑ Kubaisi B, Abu Samra K, Foster CS (2016). "Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations". Intractable Rare Dis Res. 5 (2): 61–9. doi:10.5582/irdr.2016.01014. PMC 4869584. PMID 27195187.
- ↑ McAdoo SP, Pusey CD (July 2017). "Anti-Glomerular Basement Membrane Disease". Clin J Am Soc Nephrol. 12 (7): 1162–1172. doi:10.2215/CJN.01380217. PMID 28515156.
- ↑ Ferri C, Mascia MT (January 2006). "Cryoglobulinemic vasculitis". Curr Opin Rheumatol. 18 (1): 54–63. PMID 16344620.
- ↑ Guo QY, Wu M, Wang YW, Sun GD (2017). "Hepatitis C virus-associated cryoglobulinemia with membrano-proliferative glomerulonephritis treated with prednisolone and interferon: A case report". Exp Ther Med. 14 (2): 1395–1398. doi:10.3892/etm.2017.4671. PMC 5525644. PMID 28810602.
- ↑ Sise MJ (February 2014). "Acute mesenteric ischemia". Surg. Clin. North Am. 94 (1): 165–81. doi:10.1016/j.suc.2013.10.012. PMID 24267504.
- ↑ McDonald JR (2009). "Acute infective endocarditis". Infect Dis Clin North Am. 23 (3): 643–64. doi:10.1016/j.idc.2009.04.013. PMC 2726828. PMID 19665088.
- ↑ Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008). "Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship". Mayo Clin Proc. 83 (5): 584–94. doi:10.4065/83.5.584. PMC 2718421. PMID 18452692.
- ↑ Jackman DM, Johnson BE (2005). "Small-cell lung cancer". Lancet. 366 (9494): 1385–96. doi:10.1016/S0140-6736(05)67569-1. PMID 16226617.
- ↑ Corrigan JJ, Boineau FG (November 2001). "Hemolytic-uremic syndrome". Pediatr Rev. 22 (11): 365–9. PMID 11691946.
- ↑ Byrd JC, Stilgenbauer S, Flinn IW (2004). "Chronic lymphocytic leukemia". Hematology Am Soc Hematol Educ Program: 163–83. doi:10.1182/asheducation-2004.1.163. PMID 15561682.
- ↑ Klion A (2009). "Hypereosinophilic syndrome: current approach to diagnosis and treatment". Annu. Rev. Med. 60: 293–306. doi:10.1146/annurev.med.60.062107.090340. PMID 19630574.
- ↑ Shankland KR, Armitage JO, Hancock BW (September 2012). "Non-Hodgkin lymphoma". Lancet. 380 (9844): 848–57. doi:10.1016/S0140-6736(12)60605-9. PMID 22835603.
- ↑ Lin RY (January 1986). "Serum sickness syndrome". Am Fam Physician. 33 (1): 157–62. PMID 2867672.
- ↑ Venugopal A (2014). "Disseminated intravascular coagulation". Indian J Anaesth. 58 (5): 603–8. doi:10.4103/0019-5049.144666. PMC 4260307. PMID 25535423.
- ↑ Nomura S (2016). "Advances in Diagnosis and Treatments for Immune Thrombocytopenia". Clin Med Insights Blood Disord. 9: 15–22. doi:10.4137/CMBD.S39643. PMC 4948655. PMID 27441004.
- ↑ Chiarchiaro J, Chen BB, Gibson KF (2016). "New molecular targets for the treatment of sarcoidosis". Curr Opin Pulm Med. 22 (5): 515–21. doi:10.1097/MCP.0000000000000304. PMC 5152532. PMID 27454074.
- ↑ Murdoch DR (January 2003). "Diagnosis of Legionella infection". Clin. Infect. Dis. 36 (1): 64–9. doi:10.1086/345529. PMID 12491204.
- ↑ Tsokos, George C. (2011). "Systemic Lupus Erythematosus". New England Journal of Medicine. 365 (22): 2110–2121. doi:10.1056/NEJMra1100359. ISSN 0028-4793.
- ↑ Emmungil H, Aydın SZ (2015). "Relapsing polychondritis". Eur J Rheumatol. 2 (4): 155–159. doi:10.5152/eurjrheum.2015.0036. PMC 5047229. PMID 27708954.